-
InMed Pharmaceuticals: Pushing Pharma Forward With Rare Cannabinoids
Monday, March 27, 2023 - 12:40pm | 204Read More...Jerry Griffin, VP of Sales & Marketing at BayMedica, Inc. – a subsidiary of InMed Pharmaceuticals Inc (NASDAQ: INM) – was a guest on Benzinga’s All Access. InMed is a clinical stage biopharma company that develops drugs based on rare cannabinoids. The company has several drugs...


